{"id":44639,"date":"2022-06-09T05:21:17","date_gmt":"2022-06-09T05:21:17","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=93078"},"modified":"2022-06-09T05:21:17","modified_gmt":"2022-06-09T05:21:17","slug":"international-nash-day-highlights-a-common-but-unfamiliar-liver-disease","status":"publish","type":"post","link":"https:\/\/southafricavoice.com\/international-nash-day-highlights-a-common-but-unfamiliar-liver-disease\/","title":{"rendered":"International NASH Day Highlights a Common \u2013 But Unfamiliar \u2013 Liver Disease"},"content":{"rendered":"
\n

Global Liver Institute Convenes Communities Around the Globe Today to Reverse the Growing Trend of Fatty Liver Disease<\/h4>\n

Washington, D.C., June 08, 2022 (GLOBE NEWSWIRE) — Global Liver Institute (GLI) <\/a>calls attention to NASH by leading the 5th annual International NASH Day<\/a> on June 9. The number of people with this advanced liver disease is expected to double<\/a> by 2030, but #NASHday aims to prevent this growth. Join the movement to #StopNASHNow by listening in<\/a> as 24 expert panelists from around the globe share the latest updates about the disease or adding to the conversation on social media (#NASHday). The movement permeates the globe through many locally-organized events to educate about, screen for, and prevent NASH.<\/p>\n

NASH (nonalcoholic steatohepatitis) is a serious, progressive condition in which too much fat accumulates on the liver, leading to its inflammation and injury. It is the severe form of NAFLD (nonalcoholic fatty liver disease). Modern lifestyle and dietary patterns have contributed to increased prevalence<\/a> of NASH and NAFLD around the world, and it is becoming the most common cause of liver disease. Given its widespread impact and the possibility of prevention in most cases of this disease, NASH emerges as a global health priority.<\/p>\n

\u201cWith over a hundred million people worldwide already who have NASH and several times more in the earlier stages, people have reason to know about this progressive condition and what they can do today to combat it,\u201d shared Donna R. Cryer<\/a>, president and CEO of GLI. \u201cCollective action is imperative to be certain that individuals in each community, no matter their background or environment, are informed and equipped to prevent fatty liver disease. The momentum that we build together today must advance and sustain the global fight against NASH.\u201d<\/p>\n

If you didn\u2019t know, then now you know! Even though NASH is common, it remains relatively unknown, leaving much work to be done to increase public awareness. This year, GLI and its partners join with the theme to #StopNASHNow: Even as therapies for NASH are being developed, there are many steps that people and their doctors can take today<\/em> to prevent, reverse, or slow the progression of fatty liver disease. For the 25% of adults already affected worldwide, it is due time for this life-changing knowledge.<\/p>\n